Equity financing offers a flexible, growth-focused alternative for SMEs, providing capital without the burden of fixed repayments.
This is especially valuable for businesses aiming to scale, as equity frees up cash flow to invest in growth areas, such as new market entry, infrastructure, and product development, without the need for immediate returns. Equity is particularly advantageous for projects where revenue may take time to materialise, supporting a business’s ability to plan and execute ambitious goals over a longer timeline.
De-risk and reinvest in the future
Beyond cash flow relief, equity financing enables founders to realise some of the financial value they have built in the business, allowing them to de-risk personally while reinvesting strategically. This also positions the business well for leadership transitions, as equity investors can bring stability and support before, during and after periods of change.
Secure patient capital without losing control
As the only purpose-built growth capital fund dedicated to the SME sector, ABGF was established to address these specific needs. ABGF provides patient, minority-only equity funding – typically investing between $5 million and $15 million, with an investment horizon of up to 10 years. This approach allows founders to retain control while ensuring that businesses have the necessary capital to scale sustainably. ABGF’s patient capital is uniquely suited to SMEs that require time and flexibility to achieve their growth ambitions, without the immediate pressures of buyouts or rapid repayment.
In addition to long-term equity funding, ABGF connects SMEs with an extensive network of industry experts and strategic resources, improving governance and operational capabilities that underpin long-term resilience and competitive advantage.